Topics

Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations

01:37 EDT 9 Jul 2019 | Bio-Medicine

BASEL, Switzerland (PRWEB) July 09, 2019 Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced that Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the...

Original Article: Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations

NEXT ARTICLE

More From BioPortfolio on "Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations"

Quick Search

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...